* Neuronetics Inc STIM.OQ reported a quarterly adjusted
loss
of 38 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 39 cents per share.
* Revenue rose 9.6% to $15.54 million from a year ago;
analysts
expected $15.18 million.
* Neuronetics Inc's reported EPS for the quarter was a loss
of 38
cents.
* The mean earnings estimate of analysts had fallen by
about 13.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Neuronetics Inc shares had fallen by 24.4% this
quarter and
lost 68.0% so far this year.
* The company reported a quarterly loss of $10.52 million.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $7.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
9 at 01:31 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.39 -0.38 Beat
Dec. 31 2022 -0.38 -0.30 Beat
Sep. 30 2022 -0.42 -0.28 Beat
Jun. 30 2022 -0.41 -0.39 Beat